基本信息 产品详情 公司简介 推荐产品
网站主页 HIV-1 REV PROTEIN (34-50) 抗HIV活性多肽
  • 141237-50-5

141237-50-5

Rev protein(Human immunodeficiency virus 1 fragment)
141237-50-5
询价 20mg 起订
5mg 起订
10mg 起订
四川 更新日期:2024-12-19

成都彼样生物科技有限公司

VIP6年
联系人:鲜凤玲
电话:028-81700200拨打
手机:18108052721 拨打
邮箱:2850505130@qq.com

产品详情:

中文名称:
抗HIV活性多肽
英文名称:
Rev protein(Human immunodeficiency virus 1 fragment)
CAS号:
141237-50-5
品牌:
维克奇
保存条件:
-20℃,干燥、避光、密封
纯度规格:
HPLC≥98%
产品类别:
标准品

WKQ-0014467

中文名称:抗HIV活性多肽

英文名称:Rev protein(Human immunodeficiency virus 1 fragment)

英文别名:L-Threonyl-L-arginyl-L-glutaminyl-L-alanyl-L-arginyl-L-arginyl-L-asparaginyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-tryptophyl-L-arginyl-L-α-glutamyl-L-arginyl-L-glutaminyl-L-arginine;1031: PN: WO2022192879 SEQID: 1129 claimed protein;10: PN: US20060105956 SEQID: 9 claimed sequence;10: PN: US20100228004 SEQID: 10 unclaimed protein;12: PN: JP2006282574 SEQID: 20 claimed protein;13: PN: US20080070853 SEQID: 10 unclaimed sequence;13: PN: WO2020232095 SEQID: 20 claimed protein;14: PN: WO2010040051 SEQID: 14 unclaimed sequence;14: PN: WO2021247965 SEQID: 14 claimed protein;15: PN: JP2005052083 PAGE: 4 claimed sequence;15: PN: US20100144636 SEQID: 15 unclaimed protein;15: PN: WO2022132705 SEQID: 24 claimed protein;17: PN: CN114099463 SEQID: 17 claimed protein;17: PN: WO2009147196 SEQID: 17 unclaimed protein;18: PN: WO2005035562 SEQID: 18 claimed sequence;19: PN: WO2011143111 SEQID: 20 unclaimed protein;19: PN: WO2022132520 SEQID: 19 claimed protein;1: PN: WO2007072056 FIGURE: 2B claimed sequence;20: PN: US20200360469 SEQID: 20 claimed protein;20: PN: WO2012161227 SEQID: 34 unclaimed protein;21: PN: WO2006098422 SEQID: 20 claimed sequence;21: PN: WO2007024008 SEQID: 20 claimed sequence;21: PN: WO2022132194 SEQID: 21 claimed protein;22: PN: WO2009098682 SEQID: 22 unclaimed sequence;22: PN: WO2013118863 SEQID: 22 unclaimed protein;23: PN: WO2012069657 SEQID: 41 claimed protein;25: PN: WO2015138628 SEQID: 25 claimed protein;27: PN: WO2015127094 SEQID: 27 claimed protein;29: PN: WO2017189826 SEQID: 29 claimed protein;2: PN: CN109392900 SEQID: 2 claimed sequence;2: PN: JP2017078027 SEQID: 2 claimed protein;2: PN: JP2022076808 SEQID: 2 claimed protein;2: PN: WO03080115 SEQID: 1 claimed sequence;2: PN: WO03105880 PAGE: 6 unclaimed sequence;2: PN: WO2005016343 FIGURE: 1 unclaimed sequence;310: PN: WO03012068 SEQID: 310 claimed sequence;338: PN: WO2015067712 SEQID: 368 claimed protein;338: PN: WO2015067713 SEQID: 368 claimed protein;34-50-Rev protein (Human immunodeficiency virus 1);365: PN: WO2016177899 SEQID: 368 claimed protein;37: PN: WO2010105277 SEQID: 37 unclaimed protein;37: PN: WO2013096958 SEQID: 37 unclaimed sequence;3: PN: JP2006055017 SEQID: 1 unclaimed protein;3: PN: US20040038902 SEQID: 10 unclaimed sequence;3: PN: US20060030003 SEQID: 3 unclaimed sequence;3: PN: US20090075370 SEQID: 3 unclaimed protein;3: PN: WO2005112997 SEQID: 3 unclaimed sequence;43: PN: WO2011157715 SEQID: 13 unclaimed sequence;43: PN: WO2014152391 SEQID: 88 claimed protein;4: PN: DE20201549 PAGE: 16 unclaimed sequence;4: PN: JP2003033186 PAGE: 2 claimed sequence;5: PN: JP2005013119 SEQID: 5 unclaimed sequence;5: PN: WO02098365 PAGE: 17 claimed protein;5: PN: WO03064453 PAGE: 25 unclaimed sequence;60: PN: WO2004070012 SEQID: 60 unclaimed sequence;60: PN: WO2010075575 SEQID: 60 unclaimed protein;60: PN: WO2011050334 SEQID: 60 unclaimed protein;60: PN: WO2011097181 SEQID: 60 unclaimed protein;60: PN: WO2013013105 SEQID: 60 claimed protein;60: PN: WO2016177900 SEQID: 80 claimed protein;63: PN: WO2016177898 SEQID: 368 claimed protein;69: PN: WO2011163531 SEQID: 60 unclaimed protein;6: PN: JP2004261024 SEQID: 4 claimed sequence;6: PN: JP2006246853 SEQID: 20 claimed protein;6: PN: WO0227031 PAGE: 11 claimed sequence;6: PN: WO2007050979 SEQID: 6 unclaimed sequence;7: PN: EP2394665 SEQID: 13 unclaimed sequence;7: PN: US20110117088 SEQID: 3 claimed sequence;7: PN: WO2006046978 SEQID: 4 unclaimed sequence;7: PN: WO2011157713 SEQID: 13 unclaimed sequence;7: PN: WO2019094543 SEQID: 7 claimed protein;8: PN: US20070098706 SEQID: 11 unclaimed sequence;8: PN: WO2019195851 PAGE: 54 claimed sequence;Peptide (synthetic HIV-1 Rev membrane penetrating fragment);Rev protein (Human immunodeficiency virus 1 fragment);

分子式:C97H173N51O24

分子量:2437.74

CAS号:141237-50-5

纯度:HPLC≥98%

密度:1.62±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

储存条件:-20℃,干燥、避光、密封

规格:5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装

供应单位:四川省维克奇生物科技有限公司

供应电话:028-81700200/4008005713

四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等,敬请关注!    新批次有现货,欢迎咨询。





141237-50-5;

公司简介

  成都彼样生物科技有限公司是四川省成都市一家专业从事天然药物纯化分离,集生产研发/销售于一体的公司。公司名下有四家公司“成都标样生物科技有限公司,成都超九八生物科技有限公司,四川省维克奇生物科技有限公司”。   2014年我公司与中国科学院成都生物研究所共建联合实验室,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。实验室拥有一批精密的分离纯化系统和检测设备;拥有一批技术精湛的研究队伍;拥有一套完整的质量管理体系;   公司可承接以下业务:   1、指定化合物克级---公斤级定制业务;   2、指定药材全系列的分离纯化业务;   3、新化合物的分离纯化及结构鉴定业务;   4、指

成立日期 (9年)
注册资本 100000
员工人数 10-50人
年营业额 ¥ 100万-300万
经营模式 试剂
主营行业 化学试剂,高纯试剂

抗HIV活性多肽相关厂家报价

内容声明
拨打电话 立即询价